CClinicalTrials.gg
Sign In
RecruitingNCT06107296EARLY-QoRUpdated Oct 30, 2023

Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study

An observational study in Arthroplasty, Hip Replacement and Arthroplasty, Knee Replacement, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-30.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 8 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 7 months later.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
600
Ages
18 Years and older
Sex
All
01

Study summary

Hip and knee replacements are indicated to improve long-term quality of life and pain. These long-term results may depend on the quality of the initial postoperative recovery.

However, early postoperative health status after total hip arthroplasty (THA) and total knee arthroplasty (TKA) is not accurately described. Through this retrospective study, the investigators wanted to describe the perioperative state of health monitored using the QoR-15 questionnaire for THA and TKA patients from the perioperative moment to postoperative day 28.

02

Conditions studied

  • Arthroplasty, Hip Replacement
  • Arthroplasty, Knee Replacement

Keywords

  • Arthroplasty
  • Hip Replacement
  • Knee Replacement
  • QoR-15 questionnaire
03

In context

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patient (age ≥ 18 years) Having benefited from an ATG or ATH at Strasbourg University Hospital between March 1, 2020 and December 31, 2022

Inclusion criteria

  • Adult patient (age ≥ 18 years)
  • Having benefited from an ATG or ATH at Strasbourg University Hospital between March 1, 2020 and December 31, 2022
  • Tracked with QoR-15 score
  • Patient not opposing the reuse of his data for scientific research purposes

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study
  • Patient admitted to THA for a hip fracture
  • Patient admitted for multiple THA or TKA
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
600 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mean QoR-15 score at the preoperative period and postoperative days 1, 3, 14 and 28

    Perioperative health status monitored using the QoR-15 questionnaire for THA and TKA patients from perioperative time to postoperative day 28

    Time frame: At the preoperative period and postoperative days 1, 3, 14 and 28

07

Study locations

1 of 1 sites recruiting
  • Service d'Anesthésiologie - Réanimation Chirurgicale - CHU de Strasbourg - France
    Strasbourg, 67091, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06107296
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Oct 30, 2023
Start date
Mar 1, 2023
Primary completion
Feb 2024 (estimated)
Completion
Feb 27, 2024 (estimated)
Last update
Oct 30, 2023

Study contacts

Eric NOLL, MD, PhD
Contact
eric.noll@chru-strasbourg.fr
33 3 88 12 70 76

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University Hospital, Strasbourg, France

Start the discussion